Advantage Capital Makes $2M Growth Investment in GAXtracts

June 8, 2020

Advantage Capital invested $2 million in Watkinsville-based GAXtracts to provide working capital and equipment financing under Georgia’s GARJA program. The growth capital will support facility expansion, the purchase of new equipment and is expected to create 30 new local jobs as GAXtracts scales production of hemp-derived active pharmaceutical ingredients and CBD products.

Buyers
Advantage Capital
Targets
GAXtracts
Industry
Pharmaceuticals
Location
Georgia, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.